Pages that link to "Q33457689"

The following pages link to Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. (Q33457689):

Displaying 48 items.

• Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience (Q26850621) (← links)
• Stem cell therapy for diabetes mellitus (Q27011453) (← links)
• Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes (Q28071490) (← links)
• Genetics, pathogenesis and clinical interventions in type 1 diabetes (Q28281029) (← links)
• Type 1 diabetes: translating mechanistic observations into effective clinical outcomes (Q28287737) (← links)
• Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation (Q33344421) (← links)
• Immunotherapy of type 1 diabetes: where are we and where should we be going? (Q33815506) (← links)
• The road not taken: a path to curing type 1 diabetes? (Q33859301) (← links)
• Efforts to prevent and halt autoimmune beta cell destruction (Q34077363) (← links)
• The use of FK 506 in new-onset type I diabetes in man (Q34346734) (← links)
• A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes (Q34421851) (← links)
• Novel diagnostic and therapeutic approaches for autoimmune diabetes--a prime time to treat insulitis as a disease (Q35108159) (← links)
• Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? (Q35116303) (← links)
• Noninsulin pharmacological management of type 1 diabetes mellitus (Q35153044) (← links)
• Immune intervention in type 1 diabetes. (Q35226251) (← links)
• Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset (Q35612633) (← links)
• Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin (Q35751049) (← links)
• Treatment of type 1 diabetes with anti-T-cell agents: from T-cell depletion to T-cell regulation (Q35841816) (← links)
• Immune interventions to preserve β cell function in type 1 diabetes (Q36520618) (← links)
• Prevention strategies for type 1 diabetes (Q36688658) (← links)
• Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes (Q36755915) (← links)
• George S. Eisenbarth: insulin and type 1 diabetes (Q36868176) (← links)
• Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial (Q36908165) (← links)
• Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth (Q36913132) (← links)
• Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol (Q37031038) (← links)
• New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes (Q37240506) (← links)
• Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice (Q37360439) (← links)
• Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future (Q37364899) (← links)
• The role of immunomodulation therapy in autoimmune diabetes (Q37408019) (← links)
• Teplizumab therapy for type 1 diabetes (Q37679927) (← links)
• Immune Intervention in Children with Type 1 Diabetes (Q37776436) (← links)
• GAD-Alum Immunotherapy in Type 1 Diabetes Mellitus (Q37851966) (← links)
• Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes. (Q37883029) (← links)
• Clinical immunologic interventions for the treatment of type 1 diabetes (Q38036230) (← links)
• Progress in immune-based therapies for type 1 diabetes (Q38097920) (← links)
• Targeting memory T cells in type 1 diabetes (Q38586890) (← links)
• Therapies to Preserve β-Cell Function in Type 1 Diabetes (Q38662048) (← links)
• Immunological concepts in insulin-dependent (type I) diabetes mellitus (Q39465032) (← links)
• Role of immune system modulation in prevention of type 1 diabetes mellitus (Q39505919) (← links)
• Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model (Q39793666) (← links)
• Type 1 diabetes pathogenesis - Prevention??? (Q40042478) (← links)
• Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. (Q42224371) (← links)
• Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial (Q45240370) (← links)
• Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation (Q56787009) (← links)
• Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA in New-Onset Type 1 Diabetes (Q57163295) (← links)
• Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes (Q81113817) (← links)
• Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice (Q83675715) (← links)
• Autoimmune polyglandular syndromes (Q83823303) (← links)